Foluso O. Ademuyiwa

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer

X. Cynthia, Feng Gao, Jingqin Luo et al. · Clinical Cancer Research · 2017 · 359 citations · Full text

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

Christopher A. Haiman, Gary K. Chen, Celine M. Vachon et al. · Nature Genetics · 2011 · 309 citations

Breast Oncology, Hormonal Receptor, Pathology +9

Genetic Testing in an Ethnically Diverse Cohort of High-Risk Women

Rita Nanda, L. Philip Schumm, Shelly Cummings et al. · JAMA · 2005 · 248 citations

Results from a phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC).

Tiffany A. Traina, Kathy D. Miller, Denise A. Yardley et al. · Journal of Clinical Oncology · 2015 · 149 citations

Androgen Receptor, Breast Oncology, Pathology +17

Parity and breastfeeding are protective against breast cancer in Nigerian women

Dezheng Huo, Clement Adebamowo, Temidayo O. Ogundiran et al. · British Journal of Cancer · 2008 · 137 citations · Full text